# Zinc Thymulin: The Zinc-Dependence of the Thymic Nonapeptide | Thymulin > zinc thymulin: thymulin is biologically active only when bound to one zinc ion in a 1:1 ratio. The zinc-free peptide is inactive. The defining mechanistic fact of thymulin, clipped to source. One zinc ion, one peptide, a 1:1 clip. Take the metal away and the molecule goes dark. This is the defining fact of thymulin — here is how it was shown. ## In plain English Here is the whole idea of zinc thymulin in one breath. The thymulin peptide is a chain of nine amino-acid building blocks, and on its own it does nothing. It only works once a single zinc atom snaps onto it, one zinc to one peptide. Pull the zinc off (chemists do this with a chelator, a molecule that grabs metals) and the activity vanishes. Add zinc back and it returns. That is why the active form is called zinc-thymulin — the metal is literally the on-switch, and everything else about the molecule depends on it. ## The 1:1 Zinc Clip: How It Was Proven The defining experiment is from 1982. Researchers treated serum thymic factor (FTS) with Chelex 100 — a chelator that strips metal ions out — and its biological activity in the rosette assay (a classic immune bioassay) was abolished [1]. Activity came back when zinc salts were added, with a 1:1 metal-to-peptide molar ratio giving optimal activation; other metals worked far less well [1]. From that result, the authors drew the line between two forms of the molecule: a zinc-free, biologically inactive form, and a zinc-bound, biologically active form they named thymulin (FTS-Zn) [1]. The design of that experiment is what makes it convincing. It is not a correlation — it is a remove-and-restore. Strip the metal, the activity goes; put zinc back, the activity returns; the on/off tracks the metal, not anything else in the prep [1]. The 1:1 stoichiometry matters too: optimal activation came at one zinc per peptide, which is what you would expect if a single metal ion is completing a single binding site, not coating the molecule [1]. And the specificity for zinc over other metals tells you the site is shaped for zinc in particular [1]. That is the clip-and-label moment for the whole compound. "Thymulin" is not a synonym for the peptide; it is specifically the peptide with zinc attached. The zinc-free apopeptide is the same nine residues with the switch off [1]. Everything downstream — the T-cell work, the anti-inflammatory work, the gene therapy — is built on a molecule that only exists, functionally, when the metal is on board. ## Why the Metal Matters: Conformation Zinc does not just sit there — it changes the peptide's shape. A 1994 review summarized that the zinc-bound form adopts a specific three-dimensional conformation, detectable by NMR, and that this conformation is what the molecule's activity depends on [2]. In other words, the zinc creates the active structure; the apopeptide cannot fold into it. That structural dependence is why zinc status and thymulin activity are so tightly coupled. The same review positions serum thymulin activity as a sensitive indicator of zinc status: when zinc is low, measured thymulin activity falls, and zinc supplementation corrects it in animals and humans [2]. The molecule is, in a real sense, a zinc sensor wearing a peptide coat. ## Zinc Thymulin in Humans: The Zinc-Deficiency Evidence The cleanest human data on thymulin is about zinc, not about a thymulin product. A 1988 study examined three models of mild human zinc deficiency — two dietary-restriction volunteers, plus six sickle-cell-anemia and six non-sickle-cell adults — and found serum thymulin activity was decreased even when plasma zinc looked normal, and was corrected by zinc supplementation given both in vivo and in vitro [3]. Alongside that correction, the study saw reversible shifts in T-cell subsets and IL-2 activity [3]. Read carefully, this is a study of zinc status and its effect on an endogenous peptide — not evidence that an oral or injected "zinc thymulin" product does anything in people. The human literature largely studies the metal that switches the peptide on, which is a different thing from supplementing the peptide itself. ## Apothymulin vs Zinc Thymulin: The Two Forms It helps to keep two names straight. Apothymulin is the zinc-free, inactive form of the peptide [1]. Zinc thymulin (Zn-thymulin, FTS-Zn) is the zinc-bound, active form [1]. Same sequence; one has the metal, one does not. This also explains a recurring stability note: activity requires the bound zinc ion, so anything that chelates the metal — EDTA, Chelex — knocks the molecule out, and it stays out until zinc is restored [1]. For interpreting any thymulin study, the zinc is not a footnote; it is the variable. ## Why Zinc-Dependence Complicates Every Reading Here is the catch that the zinc story creates, and it is the honest limit of this page. Because the active molecule is the metal-plus-peptide complex, reported thymulin effects are entangled with zinc status [2]. In a zinc-deficient system, even a perfectly good dose of peptide may underperform because there is not enough metal to activate it; in a zinc-replete one, the same peptide reads as more active. That makes it genuinely hard to separate a "thymulin effect" from a "zinc effect." The human zinc-deficiency work makes the entanglement concrete: measured serum thymulin activity fell with low zinc and was corrected by zinc repletion, with no change to the peptide itself — only its activation state [3]. So when a source reports that "thymulin" did something, the careful question is always: was the metal accounted for? On a thin-evidence compound, that single confound is one of the larger reasons the literature stays harder to pin down than the headline results suggest. The full [thymulin references](/references) list carries the source papers. --- A cut-and-paste research zine on thymulin — every study clipped to its source, the analog-not-native and not-a-supplement caveats taped on in plain sight, and no clinic behind the board and nothing here dispensed or sold.